Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K071903
    Date Cleared
    2007-08-02

    (23 days)

    Product Code
    Regulation Number
    874.4710
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The flexible trans-nasal esophagoscope with sheath system is intended for use in endoscopic access and examination of the larynx, esophagus and gastro-esophageal junction. The device may also be used to assist intubation.

    Device Description

    The VSI EndoSheath® Systems are sterile, single-use protective sheath systems, with or without a working channel, that are intended to cover the entire insertion tube of the flexible endoscope.

    AI/ML Overview

    This document (K071903) is a Special 510(k) Premarket Notification for a device modification, which means it relies on changes to an already cleared device and doesn't typically include extensive de novo performance studies with new acceptance criteria or human reader studies. The primary focus is on demonstrating that the modifications do not adversely affect safety and effectiveness, often by showing compliance with design controls and risk analysis.

    Therefore, many of the requested elements (like a table of acceptance criteria and performance, sample sizes for test/training sets, expert qualifications, MRMC studies, standalone performance, and detailed ground truth establishment) are not explicitly provided or applicable in the context of this specific type of submission as presented. The document states that "V & V activities, including sheath functional and performance testing, was addressed through Design Validation and Verification planning," implying that these tests were internal and likely verified against existing specifications for the predicate device, rather than new, independently established acceptance criteria for a novel device.

    However, based on the provided text, I can extract what is available and indicate where information is missing or not relevant to this type of submission.


    Acceptance Criteria and Device Performance Study Information:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Implied)Reported Device Performance
    Safety and effectiveness for intended use (unmodified)"Shown to be safe and effective for their intended use."
    Compliance with 21 CFR 820.30 Design Control requirements"Certification of compliance to 21 CFR 820.30 Design Control requirements"
    Adherence to internal Risk Analysis procedures"Description of the internal Risk Analysis procedure."
    Functional and performance integrity of the modified sheath"Sheath functional and performance testing was addressed through Design Validation and Verification planning."
    Substantial equivalence to predicate device (K031786)FDA determined the device is "substantially equivalent."

    Note: The document does not provide specific quantitative acceptance criteria or detailed performance results in the public summary. The "performance testing" mentioned is framed as part of Design Validation and Verification (V&V) activities against the device's own specifications and intended use, rather than a new comparative clinical study with defined clinical endpoints.

    2. Sample size used for the test set and the data provenance

    • Sample Size for Test Set: Not specified in the provided text. The "performance testing" refers to V&V activities.
    • Data Provenance: Not specified. As a device modification, testing would likely be internal to the manufacturer.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Number of Experts: Not applicable/specified. This type of submission (Special 510(k) for device modification) focuses on engineering and functional performance, not typically on clinical ground truth established by external experts for diagnostic accuracy.
    • Qualifications of Experts: Not applicable/specified.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Adjudication Method: Not applicable/specified. This is not a diagnostic device undergoing a typical clinical study requiring ground truth adjudication.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • MRMC Study: No. This is a medical device (protective sheath for endoscope), not an AI/diagnostic software.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Standalone Performance: Not applicable. This is a medical device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • Type of Ground Truth: Not applicable in the traditional sense of diagnostic accuracy. The "ground truth" for this device's performance would be engineering specifications, functional requirements, sterility, biocompatibility, and mechanical integrity, all verified through internal testing and validation.

    8. The sample size for the training set

    • Sample Size for Training Set: Not applicable. This is a medical device, not an AI algorithm.

    9. How the ground truth for the training set was established

    • Ground Truth Establishment for Training Set: Not applicable. This is a medical device, not an AI algorithm.

    Summary of the Study performed (as described in the 510(k) Summary):

    The submission is a Special 510(k) Premarket Notification for a Device Modification. The study supporting this clearance was not a traditional clinical trial or an AI performance study, but rather a demonstration of continued safety and effectiveness through:

    • Certification of compliance to 21 CFR 820.30 Design Control requirements: This indicates that the device's design, development, and modification processes adhere to FDA's quality system regulations.
    • Description of the internal Risk Analysis procedure: This shows that potential risks associated with the modifications were identified, analyzed, and mitigated.
    • Design Validation and Verification (V&V) activities including sheath functional and performance testing: This refers to internal testing conducted by Vision-Sciences, Inc., to ensure the modified EndoSheath® Systems meet their design specifications and intended use. The conclusion explicitly states that "Based on the indications for use, technological characteristics, performance testing and comparison to predicate devices, the modified VSI EndoSheath® Systems for use with the VSI flexible TNE scope have been shown to be safe and effective for their intended use."

    The FDA's decision of "substantial equivalence" to the predicate device (K031786) further supports this, indicating that the modifications did not raise new questions of safety or effectiveness.

    Ask a Question

    Ask a specific question about this device

    K Number
    K990354
    Device Name
    ENDOSHEATH
    Date Cleared
    1999-03-31

    (54 days)

    Product Code
    Regulation Number
    874.4760
    Reference & Predicate Devices
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Vision-Sciences EndoSheaths® are indicated for use as a protective covering for the scope during endoscopic examination of the upper airway, vocal chords and/or nasal passages.

    Device Description

    The devices described in this 510(k) are sterile, disposable, sheaths designed to fit a variety of nasolaryngoscopes. The use of an EndoSheath® eliminates the need for high-level disinfection of the scope following each procedure.

    AI/ML Overview

    The provided text describes a Special 510(k) Premarket Notification for a device modification, specifically for "Modified EndoSheath® for Flexible E". This document focuses on demonstrating substantial equivalence to predicate devices and adherence to design control requirements, rather than presenting a detailed study with acceptance criteria and device performance in the context of an AI/ML medical device.

    Therefore, the requested information, which is highly pertinent to the validation of AI/ML medical devices (such as a table of acceptance criteria and reported performance, sample sizes for test/training sets, expert qualifications, adjudication methods, MRMC studies, standalone performance, and ground truth establishment), is not present in the provided document.

    The document primarily focuses on:

    • Device Description: Sterile, disposable sheaths for nasolaryngoscopes.
    • Indications for Use: Protective covering for the scope during endoscopic examination of the upper airway, vocal chords, and/or nasal passages.
    • Safety and Performance: Mentions certification of compliance to 21 CFR 820.30 Design Control requirements and a Risk Analysis procedure. It lists "Validation testing including microbial barrier testing, tensile/elongation testing, leak testing, sheathed scope articulation testing and sheathed scope image quality evaluation" as being included in Design Validation and Verification planning. However, no specific results, acceptance criteria, or study details are provided.
    • Conclusion: States that the modified EndoSheaths® are safe and effective based on indications for use, technological characteristics, and comparison to predicate devices.

    In summary, this document does not contain the information required to answer the specific questions about acceptance criteria and a study proving the device meets those criteria, as typically expected for AI/ML device validation.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1